P44/42 MAPK (ERK1/2) Monoclonal Antibody(6C10)

The protein encoded by this gene is a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act in a signaling cascade that regulates various cellular processes such as proliferation, differentiation, and cell cycle progression in response to a variety of extracellular signals. This kinase is activated by upstream kinases, resulting in its translocation to the nucleus where it phosphorylates nuclear targets. Alternatively spliced transcript variants encoding different protein isoforms have been described.

The P44/42 MAPK (ERK1/2) Monoclonal Antibody (6C10) is a highly specific and reliable tool for the detection and analysis of the P44/42 mitogen-activated protein kinase (MAPK) pathway. This monoclonal antibody is designed to target and bind to the phosphorylated forms of ERK1 and ERK2, two key components of the MAPK signaling cascade.

With its exceptional sensitivity and specificity, the P44/42 MAPK (ERK1/2) Monoclonal Antibody (6C10) enables researchers to investigate the activation and regulation of the MAPK pathway in various biological samples. It is particularly useful in studies involving cell signaling, proliferation, differentiation, and apoptosis.

This antibody is produced using advanced monoclonal antibody technology, ensuring batch-to-batch consistency and high affinity binding. It has been extensively validated for use in various applications, including Western blotting, immunoprecipitation, immunofluorescence, and immunohistochemistry.

The P44/42 MAPK (ERK1/2) Monoclonal Antibody (6C10) is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size and concentration, allowing for easy integration into laboratory workflows.

Choose the P44/42 MAPK (ERK1/2) Monoclonal Antibody (6C10) for its exceptional performance, reliability, and versatility in investigating the intricate mechanisms of the MAPK signaling pathway.